Nonetheless, existing diagnostic techniques like prostate-specific antigen (PSA) testing and digital rectal examination (DRE) have shortcomings in precisely detecting clinically significant prostate cancer (csPCa) (2). This evidence concerns the gene KLK3 and prostate cancer.